
Cardinal Health Inc
NYSE:CAH

Intrinsic Value
The intrinsic value of one
CAH
stock under the Base Case scenario is
261.6
USD.
Compared to the current market price of 134.71 USD,
Cardinal Health Inc
is
Undervalued by 49%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cardinal Health Inc
Fundamental Analysis

Cardinal Health’s ongoing legal exposure to opioid-related lawsuits poses a significant overhang on its balance sheet and brand, potentially diverting capital resources away from strategic growth initiatives.
Cardinal Health’s scale as one of the largest global pharmaceutical distributors provides it with strong negotiation power and operational efficiencies, helping to sustain relatively stable distribution margins.

Revenue & Expenses Breakdown
Cardinal Health Inc
Balance Sheet Decomposition
Cardinal Health Inc
Current Assets | 35.8B |
Cash & Short-Term Investments | 3.8B |
Receivables | 12.4B |
Other Current Assets | 19.6B |
Non-Current Assets | 11.2B |
PP&E | 2.6B |
Intangibles | 7.4B |
Other Non-Current Assets | 1.3B |
Free Cash Flow Analysis
Cardinal Health Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cardinal Health Inc
Revenue
|
222.2B
USD
|
Cost of Revenue
|
-214.5B
USD
|
Gross Profit
|
7.6B
USD
|
Operating Expenses
|
-5.4B
USD
|
Operating Income
|
2.3B
USD
|
Other Expenses
|
-956m
USD
|
Net Income
|
1.3B
USD
|
CAH Profitability Score
Profitability Due Diligence
Cardinal Health Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Cardinal Health Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CAH Solvency Score
Solvency Due Diligence
Cardinal Health Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Score
Cardinal Health Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CAH Price Targets Summary
Cardinal Health Inc
According to Wall Street analysts, the average 1-year price target for
CAH
is 146.23 USD
with a low forecast of 120.31 USD and a high forecast of 163.8 USD.
Dividends
Current shareholder yield for CAH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CAH
stock under the Base Case scenario is
261.6
USD.
Compared to the current market price of 134.71 USD,
Cardinal Health Inc
is
Undervalued by 49%.